home / stock / lacqw / lacqw quote
Last: | $0.7699 |
---|---|
Change Percent: | -14.46% |
Open: | $0.8 |
Close: | $0.7699 |
High: | $0.8 |
Low: | $0.75 |
Volume: | 13,759 |
Last Trade Date Time: | 06/03/2021 04:43:14 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7699 | $0.8 | $0.7699 | $0.8 | $0.75 | 13,759 | 06-03-2021 |
$0.9 | $0.907749 | $0.9 | $0.9654 | $0.8144 | 20,293 | 06-02-2021 |
$1.04 | $1 | $1.04 | $1.04 | $0.97 | 701 | 06-01-2021 |
$1.09 | $1.1 | $1.09 | $1.1002 | $0.98 | 13,830 | 05-31-2021 |
$1.09 | $1.1 | $1.09 | $1.1002 | $0.98 | 13,830 | 05-28-2021 |
$1.06 | $0.97 | $1.06 | $1.06 | $0.95 | 30,938 | 05-27-2021 |
$0.93 | $0.91 | $0.93 | $0.93 | $0.91 | 6,595 | 05-26-2021 |
$0.91 | $0.765 | $0.91 | $0.91 | $0.76 | 23,888 | 05-25-2021 |
$0.825 | $0.85 | $0.825 | $0.86 | $0.75 | 5,257 | 05-24-2021 |
$0.85 | $0.85 | $0.85 | $0.88 | $0.82 | 31,364 | 05-21-2021 |
$0.85 | $0.8271 | $0.85 | $0.8595 | $0.8271 | 9,088 | 05-20-2021 |
$0.7999 | $0.77 | $0.7999 | $0.8499 | $0.75 | 6,185 | 05-19-2021 |
$0.78 | $0.849899 | $0.78 | $0.8499 | $0.74 | 50,177 | 05-18-2021 |
$0.78 | $0.73 | $0.78 | $0.8594 | $0.7201 | 3,453 | 05-17-2021 |
$0.8595 | $0.77 | $0.8595 | $0.8595 | $0.77 | 19,140 | 05-14-2021 |
$0.85 | $0.8 | $0.85 | $0.88 | $0.76 | 8,216 | 05-13-2021 |
$0.8799 | $0.899899 | $0.8799 | $0.8999 | $0.791 | 2,095 | 05-12-2021 |
$0.8201 | $0.81 | $0.8201 | $0.85 | $0.7711 | 21,904 | 05-11-2021 |
$0.87 | $0.8525 | $0.87 | $0.9 | $0.81 | 17,603 | 05-10-2021 |
$0.81 | $0.89 | $0.81 | $0.9 | $0.8 | 5,401 | 05-07-2021 |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc Wt Exp 06/30/2022 Company Name:
LACQW Stock Symbol:
NASDAQ Market:
SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug ab...
SAN DIEGO, July 26, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug ab...
SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug ab...